Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001415889-24-030004

VP, Pharmaceutical Development acquired 29,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cappello Joseph VP, Pharmaceutical Development 2024-12-18 Grant or award +29,000 43,653 D
Derivatives
Cappello Joseph VP, Pharmaceutical Development 2024-12-18 Grant or award · Stock Option (right to buy) +39,000 39,000 D
Loading xslF345X05/form4-12212024_011239.xml…